The China Shanghai Composite Index experienced a slight decline of 0.25% today, although it has shown a notable increase of 5.73% over the past month. In the large-cap sector, Novoray Corp. emerged as the top performer with a return of 16.56%, while Shenzhen Salubris Pharmaceuticals Co., Ltd. faced challenges, recording a decline of 10.0%. In the mid-cap category, Xiamen Voke Mold & Plastic Engineering Co., Ltd. led the way with a robust return of 20.0%, contrasting with Guangdong Huate Gas Co., Ltd., which saw a decrease of 10.87%. The small-cap segment also showcased strong performance, with Jiangsu Tongguang Electronic Wire & Cable Corp. Ltd. achieving a return of 20.0%, while Jiangsu Feymer Technology Co., Ltd. struggled, posting a decline of 11.72%. Overall, the market's advance-decline ratio indicates a challenging environment, with 1,226 stocks advancing against 3,739 declining, resulting in a ratio of 0.33x. This trend is reflected across large-cap, mid-cap, and small-cap stocks, highlighting the prevailing market pressures.